The Pan-American League of Associations for Rheumatology (PANLAR) has stated its position regarding biosimilars. This infographic is based on the PANLAR document published on the Clinical Rheumatology journal. The recommendations are necessary so that the use of biosimilars may be done in a safe environment for patients and that also provide peace of mind to the physicians in all the countries of America.